The molecular clock: a focus on chronopharmacological strategies for a possible control of aminoglycoside renal toxicity

References

• Halberg F. Chronobiology. Annu Rev Physiol. 1969;31:675–725.
   Web of Science ®Google Scholar
• Ralph MR, Foster RG, Davis FC, Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science. 1990;247(4945):975–978.
   PubMed Web of Science ®Google Scholar
• Muñoz M, Peirson SN, Hankins MW, Foster RG. Long-term constant light induces constitutive elevated expression of mPER2 protein in the murine SCN: a molecular basis for Aschoff’s rule? J Biol Rhythms. 2005;20(1):3–14.
   Web of Science ®Google Scholar
• Albrecht U. Invited review: regulation of mammalian circadian clock genes. J Appl Physiol. 2002;92(3):1348–1355.
   PubMed Web of Science ®Google Scholar
• Cermakian N, Boivin DB. A molecular perspective of human circadian rhythm disorders. Brain Res Rev. 2003;42(3):204–220.
   Google Scholar
• Hastings MH, Herzog ED. Clock genes, oscillators, and cellular networks in the suprachiasmatic nuclei. J Biol Rhythms. 2004;19(5):400–413.
   Web of Science ®Google Scholar
• Damiola F, Le Minh N, Preitner N, Kornmann B, Fleury-Olela F, Schibler U. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev. 2000;14(23):2950–2961.
   PubMed Web of Science ®Google Scholar
• Hirao J, Arakawa S, Watanabe K, Ito K, Furukawa T. Effects of restricted feeding on daily fluctuations of hepatic functions including p450 monooxygenase activities in rats. J Biol Chem. 2006;281(6):3165–3171.
   Web of Science ®Google Scholar
• Sheward WJ, Maywood ES, French KL, et al. Entrainment to feeding but not to light: circadian phenotype of VPAC2 receptor-null mice. J Neurosci. 2007;27(16):4351–4358.
   Web of Science ®Google Scholar
• Hayashi Y, Ushijima K, Ando H, et al. Influence of a time-restricted feeding schedule on the daily rhythm of abcb1a gene expression and its function in rat intestine. J Pharmacol Exp Ther. 2010;335(2):418–423.
   PubMed Web of Science ®Google Scholar
• Reinberg AE. Concepts in chronopharmacology Annu Rev Pharmacol Toxicol. 1992;32:51–66.
   PubMed Web of Science ®Google Scholar
• Ritschel WA, Forusz H. Chronopharmacology, a review of drugs studied. Methods Find Exp Clin Pharmacol. 1994;16(1):57–75.
   PubMed Web of Science ®Google Scholar
• Bruguerolle B. Chronopharmacokinetics. Current status. Clin Pharmacokinet. 1998;35(2):83–94.
   Web of Science ®Google Scholar
• Drusano GL. Antimicrobial pharmacodynamics: critical interactions of ‘bug and drug’. Nat Rev Microbiol. 2004;2(4):289–300.
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A. Circadian rhythms in mammalian neurotransmitter receptors. Prog Neurobiol. 1987;29(3):219–259.
   Web of Science ®Google Scholar
• Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother. 1999;43(4):727–737.
   PubMed Web of Science ®Google Scholar
• Prins JM, Weverling GJ, de Blok K, van Ketel RJ, Speelman P Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother. 1996;40(11):2494–2499.
   Web of Science ®Google Scholar
• Quiros Y, Vicente-Vicente L, Morales AI, Lopez-Novoa JM, Lopez- Hernandez FJ. An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin. Toxicol Sci. 2011;119(2):245–256.
   PubMed Web of Science ®Google Scholar
• Rao SC, Ahmed M, Hagan R. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev. 2006;25(1):CD005091.
   Google Scholar
• Rybak MJ, Abate BJ, Kang SL, Ruffing MJ, Lerner SA, Drusano GL. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother. 1999;43(7):1549–1555.
   PubMed Web of Science ®Google Scholar
• Bourguignon L, Goutelle S, De Saint-Martin JB, Maire P, Ducher M. Evaluation of various gentamicin dosage regimens in geriatric patients: a simulation study. Fundam Clin Pharmacol. 2010;24(1):109–113.
   Web of Science ®Google Scholar
• Yoshiyama Y, Kobayashi T, Tomonaga F, Nakano S. Chronotoxical study of gentamicin induced nephrotoxicity in rats. J Antibiot (Tokyo). 1992;45(5):806–808.
   PubMed Web of Science ®Google Scholar
• Beauchamp D, Collin P, Grenier L, et al. Effects of fasting on temporal variation in nephrotoxicity of gentamicin in rats. Antimicrob Agents Chemother. 1996;40(3):670–676.
   PubMed Web of Science ®Google Scholar
• Beauchamp D, Guimont C, Grenier L, et al. Time-restricted feeding schedules modify temporal variation of gentamicin experimental nephrotoxicity. Antimicrob Agents Chemother. 1997;41(7):1468–1474.
   Web of Science ®Google Scholar
• Julien N, Karzasi M, Labrecque G, Beauchamp D, Thibault L. Temporal modulation of nephrotoxicity, feeding, and drinking in gentamicin- treated rats. Physiol Behav. 2000;68(4):533–541.
   Web of Science ®Google Scholar
• Paquette M, Plante I, Labrecque G, Beauchamp D, Thibault L. Dietary composition alters gentamicin-induced nephrotoxicity in rats. Physiol Behav. 2002;77(1):141–150.
   Web of Science ®Google Scholar
• Lin L, Grenier I, Bergeron Y, et al. Temporal changes of pharmacokinetic s, nephrotoxicity and subcellular distribution of tobramycin in rats. Antimicrob Agents Chemother. 1994;38(1):54–60.
   PubMed Web of Science ®Google Scholar
• Lin L, Grenier L, Theriault G, et al. Nephrotoxicity of low doses of tobramycin in rats: effect of the time of administration. Life Sci 1994;55(3):169–177.
   Web of Science ®Google Scholar
• Lin L, Grenier L, Guimont C, et al. Circadian variation in the intracortical accumulation kinetics of tobramycin in conscious rats. Chronobiol Int. 1995;12(3):188–194.
   Web of Science ®Google Scholar
• Yoshiyama Y, Nishikawa S, Sugiyama T, et al. Influence of circadian-stage-dependent dosing schedule on nephrotoxicity and pharmacokinetics of isepamicin in rats. Antimicrob Agents Chemother. 1993;37(9):2042–2053.
   PubMed Web of Science ®Google Scholar
• Yoshiyama Y, Grenier L, Gourde P, et al. Temporal variation in nephrotoxicity of low doses of isepamicin in rats. Antimicrob Agents Chemother. 1996;40(3):802–806.
   Web of Science ®Google Scholar
• Beauchamp D, Labrecque G. Aminoglycoside nephrotoxicity: do time and frequency of administration matter? Curr Opin Crit Care. 2001;7(6): 401^08.
   Google Scholar
• Beauchamp D, Labrecque G. Chronobiology and chronotoxicology of antibiotics and aminoglycosides. Adv Drug Deliv Rev. 2007;59(9–10):896–903.
   PubMed Web of Science ®Google Scholar
• Prins JM, Weverling GJ, van Ketel RJ, Speelman P. Circadian variations in serum levels and the renal toxicity of aminoglycoside in patients. Clin Pharmacol Ther. 1997;62(1):106–1011.
   Web of Science ®Google Scholar
• Fauvelle F, Perrin P, Belfayol L, et al. Fever and associated changes in glomerular filtration rate erase anticipated diurnal variations in aminoglycoside pharmacokinetics. Antimicrob Agents Chemother. 1994;38(3):620–623.
   Web of Science ®Google Scholar
• Rougier F, Claude D, Maurin M, et al. Aminoglycoside nephrotoxicity: modeling, simulation, and control. Antimicrob Agents Chemother. 2003;47(3):1010–1016.
   PubMed Web of Science ®Google Scholar
• Pons M, Forpomés O, Espagnet S, Cambar J. Relationship between circadian changes in renal hemodynamics and circadian changes in urinary glycosaminoglycan excretion in normal rats. Chronobiol Int. 1996;13(5):349–358.
   PubMed Web of Science ®Google Scholar
• Pons M, Schnecko A, Witte K, Lemmer B, Waterhouse JM, Cambar J. Circadian rhythms in renal function in hypertensive TGR (mRen-2) rats and their normotensive controls. Am J Physiol 1996;271(4 Pt 2): R1002–R1008.
   Google Scholar
• Pons M, Mellado M, Cambar J. Effects of cyclosporin A on circadian changes in urinary water, sodium and potasium excretion in conscious unrestained chronically cannulated rats. Biol Rythms Res. 1997;28:56–68.
   Web of Science ®Google Scholar
• Voogel AJ, Koopman MG, Hart AA, van Montfrans GA, Arisz L. Circadian rhythms in systemic hemodynamics and renal function in healthy subjects and patients with nephrotic syndrome. Kidney Int. 2001;59(5):1873–1880.
   PubMed Web of Science ®Google Scholar
• Kamperis K, Hansen MN, Hagstroem S, Hvistendahl G, Djurhuus JC, Rittig S. The circadian rhythm of urine production, and urinary vasopressin and prostaglandin E2 excretion in healthy children. J Urol 2004;171(6 Pt 2):2571–2575.
   PubMed Web of Science ®Google Scholar
• Widerhon N, Díaz D, Picco E, Rebuelto M, Encinas T, Carlos Boggio J. Chronopharmacokinetic study of gentamicin in dogs. Chronobiol Int. 2005;22(4):731–739.
   PubMed Web of Science ®Google Scholar
• Bleyzac N, Allard-Latour B, Laffont A, Mouret J, Jelliffe R, Maire P Diurnal changes in the pharmacokinetic behavior of amikacin. Ther DrugMonit. 2000;22(3):307–312.
   PubMed Web of Science ®Google Scholar
• LeBrun M, Grenier L, Gourde P, Bergeron M, Labrecque G, Beauchamp D. Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administration. Antimicrob Agents Chemother. 1999;43(5):1020–1026.
   PubMed Web of Science ®Google Scholar
• Wu T, Ni Y, Dong Y, et al. Regulation of circadian gene expression in the kidney by light and food cues in rats. Am J Physiol Regul Integr Comp Physiol. 2010;298(3):R635–R641.
   Web of Science ®Google Scholar
• Zuber AM, Centeno G, Pradervand S, et al. Molecular clock is involved in predictive circadian adjustment of renal function. Proc Natl Acad Sci USA. 2009;106(38):16523–16528.
   PubMed Web of Science ®Google Scholar
• Firsov D, Tokonami N, Bonny O. Role of the renal circadian timing system in maintaining water and electrolytes homeostasis. Mol Cell Endocrinol. 2011. doi: 10.1016/j.mce.2011.06.037.
   Web of Science ®Google Scholar
• Gumz ML, Stow LR, Lynch IJ, et al. The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice. J Clin Invest. 2009;119(8):2423–2434.
   Web of Science ®Google Scholar
• Saifur Rohman M, Emoto N, Nonaka H, et al. Circadian clock genes directly regulate expression of the Na(+)/H(+) exchanger NHE3 in the kidney. Kidney Int. 2005;67(4):1410–1419.
   PubMed Web of Science ®Google Scholar
• Nishinaga H, Komatsu R, Doi M, et al. Circadian expression of the Na+/H+ exchanger NHE3 in the mouse renal medulla. Biomed Res. 2009;30(2):87–93.
   Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res. 2010;181:127–151.
   PubMed Web of Science ®Google Scholar
• Ramirez-Rodríguez G, Meza I, Hernández ME, Castillo A, Benítez- King G. Melatonin induced cyclic modulation of vectorial water transport in kidney-derived MDCK cells. Kidney Int. 2003;63(4):1356–1364.
   Web of Science ®Google Scholar
• Ozbek E, Turkoz Y, Sahna E, Ozugurlu F, Mizrak B, Ozbek M. Melatonin administration prevents the nephrotoxicity induced by gentamicin. BJU Int. 2000;85(6):742–746.
   PubMed Web of Science ®Google Scholar
• Sener G, Sehirli AO, Altunbas HZ, et al. Melatonin protects against gentamicin-induced nephrotoxicity in rats. J Pineal Res. 2002;32(4):231–236.
   PubMed Web of Science ®Google Scholar
• Parlakpinar H, Ozer MK, Sahna E, Vardi N, Cigremis Y, Acet A. Amikacin-induced acute renal injury in rats: protective role of melatonin. J Pineal Res. 2003;35(2):85–90.
   PubMed Web of Science ®Google Scholar
• Kim JB, Jung JY, Ahn JC, Rhee CK, Hwang HJ. Antioxidant and anti- apoptotic effect of melatonin on the vestibular hair cells of rat utricles. Clin Exp Otorhinolaryngol. 2009;2(1):6–12.
   Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Korkmaz A, Fuentes-Broto L. Drug-mediated ototoxicity and tinnitus: alleviation with melatonin. J Physiol Pharmacol. 2011;62(2):151–157.
   Web of Science ®Google Scholar
• Odera K, Goto S, Takahashi R. Age-related change of endocytic receptors megalin and cubilin in the kidney in rats. Biogerontology. 2007;8(5):505–515.
   Web of Science ®Google Scholar
• Christensen EI, Verroust PJ, Nielsen R. Receptor-mediated endocytosis in renal proximal tubule. Pflugers Arch. 2009;458(6):1039–1048.
   Web of Science ®Google Scholar
• Saito A, Sato H, Iino N, Takeda T. Molecular mechanisms of receptor- mediated endocytosis in the renal proximal tubular epithelium. J Biomed Biotechnol. 2010;2010:403272.
   PubMed Web of Science ®Google Scholar
• Moestrup SK, Cui S, Vorum H, et al. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest. 1995;96(3):1404–1413.
   PubMed Web of Science ®Google Scholar
• Antoine DJ, Srivastava A, Pirmohamed M, Park BK. Statins inhibit aminoglycoside accumulation and cytotoxicity to renal proximal tubule cells. Biochem Pharmacol. 2010;79(4):647–654.
   PubMed Web of Science ®Google Scholar
• Vegt E, Melis M, Eek A, et al. Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice. Eur J Nucl Med Mol Imaging. 2011;38(4):623–632.
   PubMed Web of Science ®Google Scholar
• Verroust PJ, Kozyraki R. Cubilin: physiopathologic role and relationship with megalin. Med Sci (Paris). 2003;19(3):337–343. French.
   Web of Science ®Google Scholar
• Schmitz C, Hilpert J, Jacobsen C, et al. Megalin deficiency offers protection from renal aminoglycoside accumulation. J Biol Chem. 2002;277(1):618–622.
   PubMed Web of Science ®Google Scholar
• Chlon TM, Taffany DA, Welsh J, Rowling MJ. Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells. J Nutr. 2008;138(7):1323–1328.
   Web of Science ®Google Scholar
• Marzolo MP, Farfán P. New insights into the roles of megalin/LRP2 and the regulation of its functional expression. Biol Res. 2011;44(1):89–105.
   PubMed Web of Science ®Google Scholar
• Cabezas F, Lagos J, Céspedes C, Vio CP, Bronfman M, Marzolo MP Megalin/LRP2 expression is induced by peroxisome proliferator- activated receptor -alpha and -gamma: implications for PPARs’ roles in renal function. PLoS One. 2011;6(2):e16794.
   Web of Science ®Google Scholar
• Teboul M, Gréchez-Cassiau A, Guillaumond F, Delaunay F How nuclear receptors tell time. J Appl Physiol. 2009;107(6):1965–1971.
   Web of Science ®Google Scholar
• Yang X. A wheel of time: the circadian clock, nuclear receptors, and physiology. Genes Dev. 2010;24(8):741–747.
   Web of Science ®Google Scholar
• Nakamura K, Inoue I, Takahashi S, Komoda T, Katayama S. Cryptochrome and period proteins are regulated by the CLOCK/ BMAL1 gene: crosstalk between the PPARs/RXRalpha-Regulated and CLOCK/BMAL1-regulated systems. PPAR Res. 2008;2008:348610.
   PubMed Web of Science ®Google Scholar
• Schmutz I, Ripperger JA, Baeriswyl-Aebischer S, Albrecht U. The mammalian clock component PERIOD2 coordinates circadian output by interaction with nuclear receptors. Genes Dev. 2010;24(4):345–357.
   PubMed Web of Science ®Google Scholar
• Oishi K, Shirai H, Ishida N. CLOCK is involved in the circadian- transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice. Biochem J. 2005;386(Pt 3):575–581.
   PubMedGoogle Scholar
• Oishi K, Uchida D, Ishida N. Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver. FEBS Lett. 2008;582(25–26):3639–3642.
   Web of Science ®Google Scholar
• Charoensuksai P, Xu W PPARs in rhythmic metabolic regulation and implications in health and disease. PPAR Res. 2010;2010. pii: 243643.
   Web of Science ®Google Scholar
• Grimaldi B, Bellet MM, Katada S, et al. PER2 controls lipid metabolism by direct regulation of PPARy. Cell Metab. 2010;12(5):509–520.
   PubMed Web of Science ®Google Scholar
• Inoue I, Shinoda Y, Ikeda M, et al. CLOCK/BMAL1 is involved in lipidmetabolism via transactivation of the peroxisome proliferator- activated receptor (PPAR) response element. J Atheroscler Thromb. 2005;12(3):169–174.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Inoue I, Nakajima Y, et al. A promoter in the novel exon of hPPARgamma directs the circadian expression of PPARgamma. J Atheroscler Thromb. 2010;17(1):73–83.
   Web of Science ®Google Scholar
• Yang X, Downes M, Yu RT, et al. Nuclear receptor expression links the circadian clock to metabolism. Cell. 2006;126(4):801–810.
   PubMed Web of Science ®Google Scholar
• Balasubramaniam S, Szanto A, Roach PD. Circadian rhythm in hepatic low-density-lipoprotein (LDL)-receptor expression and plasma LDL levels. Biochem J. 1994;298(Pt 1):39–43.
   Google Scholar
• Kudo T, Kawashima M, Tamagawa T, Shibata S. Clock mutation facilitates accumulation of cholesterol in the liver of mice fed a cholesterol and/or cholic acid diet. Am J Physiol Endocrinol Metab. 2008;294(1):E120–E130.
   PubMed Web of Science ®Google Scholar
• Biemesderfer D, Nagy T, DeGray B, Aronson PS. Specific association of megalin and the Na+/H+ exchanger isoform NHE3 in the proximal tubule. J Biol Chem. 1999;274(25):17518–17524.
   PubMed Web of Science ®Google Scholar